{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T21:28:52Z","timestamp":1774560532907,"version":"3.50.1"},"reference-count":106,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[1997,8,1]],"date-time":"1997-08-01T00:00:00Z","timestamp":870393600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[1997,8]]},"DOI":"10.1016\/s0002-9343(97)00027-2","type":"journal-article","created":{"date-parts":[[2002,7,25]],"date-time":"2002-07-25T20:40:36Z","timestamp":1027629636000},"page":"152-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":159,"title":["Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease"],"prefix":"10.1016","volume":"103","author":[{"given":"Steven M.","family":"Haffner","sequence":"first","affiliation":[]},{"given":"Heikki","family":"Miettinen","sequence":"additional","affiliation":[]}],"member":"78","reference":[{"key":"10.1016\/S0002-9343(97)00027-2_BIB1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2337\/diab.37.6.667","article-title":"Lilly Lecture 1987: The triumvirate: \u03b2-cell, muscle, liver: a collusion responsible for type II diabetes","volume":"37","author":"DeFronzo","year":"1988","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB2","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"1988 Banting Lecture: role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.2337\/diab.41.6.715","article-title":"Prospective analyses of the insulin resistance syndrome (Syndrome X)","volume":"41","author":"Haffner","year":"1992","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB4","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1093\/oxfordjournals.aje.a116768","article-title":"How good a marker is insulin level for insulin resistance?","volume":"137","author":"Laakso","year":"1993","journal-title":"Am J Epidemiol."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB5","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.2337\/diab.43.12.1490","article-title":"Proinsulin and specific insulin concentrations in high and low risk populations for type II diabetes","volume":"43","author":"Haffner","year":"1994","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB6","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM198903163201105","article-title":"Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance","volume":"320","author":"Zavaroni","year":"1989","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB7","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1056\/NEJM198708063170605","article-title":"Insulin resistance in essential hypertension","volume":"317","author":"Ferrannini","year":"1987","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diacare.14.3.173","article-title":"Insulin resistance: a multi-faceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease","volume":"14","author":"DeFronzo","year":"1991","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1210\/jcem.76.3.8445008","article-title":"Editorial: Insulin and blood pressure: fact or fantasy?","volume":"76","author":"Haffner","year":"1993","journal-title":"J Clin Endocrinol Metab."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1365-2362.1989.tb00269.x","article-title":"Essential hypertension and insulin resistance in non-insulin dependent diabetes","volume":"19","author":"Laakso","year":"1989","journal-title":"Eur J Clin Invest."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB11","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1056\/NEJM199103143241105","article-title":"Racial differences in the relation between blood pressure and insulin resistance","volume":"324","author":"Saad","year":"1991","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB12","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1161\/01.HYP.16.6.706","article-title":"Insulin resistance and blood pressure in young black men","volume":"16","author":"Falkner","year":"1990","journal-title":"Hypertension."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB13","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1161\/01.HYP.20.1.38","article-title":"Clustering of cardiovascular risk factors in confirmed prehypertensive individuals","volume":"20","author":"Haffner","year":"1992","journal-title":"Hypertension."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB14","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/01.ATV.11.6.1636","article-title":"Relation of fasting plasma insulin concentrations to high density lipoprotein cholesterol and triglyceride concentrations in men","volume":"11","author":"Laws","year":"1991","journal-title":"Arterioscler Thromb."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB15","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/0026-0495(88)90157-6","article-title":"Relationship between lipoprotein levels and in vivo insulin action in normal young white men","volume":"37","author":"Garg","year":"1988","journal-title":"Metabolism."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB16","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1001\/jama.1988.03410130125037","article-title":"Low density lipoprotein subclass patterns and risk of myocardial infarction","volume":"260","author":"Austin","year":"1988","journal-title":"JAMA."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB17","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1172\/JCI116541","article-title":"Insulin resistance and hyperinsulinemia in individuals with small dense, low density lipoprotein particles","volume":"92","author":"Reaven","year":"1993","journal-title":"J Clin Invest."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB18","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/BF00401766","article-title":"Small dense LDL is associated with the insulin resistance syndrome","volume":"38","author":"Haffner","year":"1995","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB19","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJM198610093151501","article-title":"Coronary angioscopy in patients with unstable angina pectoris","volume":"315","author":"Sherman","year":"1986","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB20","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1056\/NEJM198512193132501","article-title":"Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction","volume":"313","author":"Hamsten","year":"1985","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB21","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/0026-0495(86)90209-X","article-title":"Correlation between blood fibrinolytic activity, plasminogen activator inhibitor level, plasma insulin level, and relative body weight in normal and obese subjects","volume":"35","author":"Vague","year":"1986","journal-title":"Metabolism."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB22","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1161\/01.ATV.14.8.1264","article-title":"Insulin sensitivity is not an independent determinant of plasma plasminogen activator inhibitor-1 activity","volume":"14","author":"Mykk\u00e4nen","year":"1994","journal-title":"Arterioscler Thromb."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB23","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/BF00403280","article-title":"Increased plasma plasminogen activator inhibitor-1 levels: a possible link between insulin resistance and atherothrombosis","volume":"34","author":"Juhan-Vague","year":"1991","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB24","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/diab.23.2.105","article-title":"Morbidity and mortality in diabetics in the Framingham population: sixteen-year follow-up","volume":"23","author":"Garcia","year":"1974","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB25","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","article-title":"Multiple Risk Factor Intervention Trial Research Group. Diabetes, other risk factors and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial","volume":"16","author":"Stamler","year":"1993","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB26","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/0002-8703(88)90220-7","article-title":"The Prospective Cardiovascular Munster (PROCAM) Study: prevalence of hyperlipidemia in persons with hypertension and\/or diabetes mellitus and the relationship to coronary heart disease","volume":"116","author":"Assmann","year":"1988","journal-title":"Am Heart J."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB27","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1007\/BF00290267","article-title":"Prevalence of small vessel and large vessel disease in diabetic patients from 14 centres: the World Health Organization Multinational Study of vascular disease in diabetics","volume":"28","year":"1985","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB28","doi-asserted-by":"crossref","first-page":"2864","DOI":"10.1001\/jama.1988.03410190112033","article-title":"Glycosylated hemoglobin predicts the incidence and progression of diabetic retinopathy","volume":"260","author":"Klein","year":"1988","journal-title":"JAMA."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB29","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(80)92651-3","article-title":"Coronary heart disease risk and impaired glucose tolerance: The Whitehall Study","volume":"1","author":"Fuller","year":"1980","journal-title":"Lancet."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB30","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00281114","article-title":"Type II (non-insulin-dependent) diabetes mellitus and coronary heart disease\u2014chicken, egg, or neither?","volume":"26","author":"Jarrett","year":"1984","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB31","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/BF01219704","article-title":"Differences in cardiovascular morbidity and mortality between previously known and newly diagnosed adult diabetics","volume":"13","author":"Herman","year":"1977","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB32","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1161\/01.CIR.88.4.1421","article-title":"Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with non-insulin dependent diabetes","volume":"88","author":"Laakso","year":"1993","journal-title":"Circulation."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diab.43.8.960","article-title":"NIDDM and its metabolic control predict coronary heart disease in the elderly subjects","volume":"43","author":"Kuusisto","year":"1994","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB34","doi-asserted-by":"crossref","first-page":"179","DOI":"10.2337\/diab.36.2.179","article-title":"Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years","volume":"36","author":"Sicree","year":"1987","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB35","doi-asserted-by":"crossref","first-page":"283","DOI":"10.2337\/diab.39.3.283","article-title":"Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body fat distribution","volume":"39","author":"Haffner","year":"1990","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB36","doi-asserted-by":"crossref","first-page":"104","DOI":"10.2337\/diacare.39.1.104","article-title":"Association of elevated fasting C-peptide level and increased intra-abdominal fat distribution with development of type II diabetes in Japanese-American men","volume":"39","author":"Bergstrom","year":"1990","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB37","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2337\/diab.40.7.796","article-title":"Risk factors for NIDDM in white populations: Paris Prospective Study","volume":"40","author":"Charles","year":"1991","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB38","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/BF02743273","article-title":"Cardiovascular disease risk factors as predictors of type II (non-insulin-dependent) diabetes mellitus in elderly subjects","volume":"36","author":"Mykk\u00e4nen","year":"1993","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB39","doi-asserted-by":"crossref","first-page":"909","DOI":"10.7326\/0003-4819-113-12-909","article-title":"Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents","volume":"113","author":"Warram","year":"1990","journal-title":"Ann Intern Med."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB40","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin dependent diabetes mellitus. Prospective studies of Pima Indians","volume":"329","author":"Lillioja","year":"1993","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB41","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/diacare.18.2.258","article-title":"Kelly West Lecture 1994. Hyperglycemia and microvascular and macrovascular disease in diabetes","volume":"18","author":"Klein","year":"1995","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB42","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.2337\/diab.45.9.1253","article-title":"Early atherosclerosis is retarded by improved long-term blood glucose control in patients with IDDM","volume":"45","author":"Jensen-Urstad","year":"1996","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB43","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/01.ATV.15.4.431","article-title":"Relation of glycohemoglobin and adiposity to atherosclerosis in youth. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group","volume":"15","author":"McGill","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB44","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/oxfordjournals.aje.a115519","article-title":"Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin dependent diabetes mellitus in a community of older adults","volume":"131","author":"McPhillips","year":"1990","journal-title":"Am J Epidemiol."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB45","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archinte.1975.00330060055007","article-title":"Major factors in the development of diabetes mellitus in 10,000 men","volume":"135","author":"Medalie","year":"1975","journal-title":"Arch Int Med."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB46","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1001\/jama.1990.03440210043030","article-title":"Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes?","volume":"263","author":"Haffner","year":"1990","journal-title":"JAMA."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00006","article-title":"Do non-insulin dependent diabetes mellitus and cardiovascular disease share common antecedents?","volume":"124","author":"Stern","year":"1996","journal-title":"Ann Intern Med."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB48","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2337\/diacare.2.2.154","article-title":"Coronary heart disease incidence and cardiovascular mortality in Busselton with reference to glucose and insulin concentrations","volume":"2","author":"Welborn","year":"1979","journal-title":"Diabetes Care."},{"issue":"Suppl","key":"10.1016\/S0002-9343(97)00027-2_BIB49","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.0954-6820.1985.tb08888.x","article-title":"Plasma insulin as coronary heart disease risk factor: relationship to other risk factors and predictive during 912 year follow-up of the Helsinki Policeman Study population","volume":"701","author":"Py\u00f6r\u00e4l\u00e4","year":"1985","journal-title":"Acta Med Scand."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB50","first-page":"41","article-title":"Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study 10 years later","volume":"15(Suppl)","author":"Eschwege","year":"1985","journal-title":"Horm Metab Res."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB51","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despr\u00e9s","year":"1996","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB52","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/1047-2797(94)90041-8","article-title":"Insulin as a predictor of coronary heart disease: interaction with Apolipoprotein E phenotype. A report from the Multiple Risk Factor Intervention Trial","volume":"4","author":"Orchard","year":"1994","journal-title":"Ann Epidemiol."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB53","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/BF00429098","article-title":"Hyperinsulinemia is not a major coronary risk factor in elderly men. The study of men born in 1913","volume":"35","author":"Welin","year":"1992","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB54","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1093\/oxfordjournals.aje.a117174","article-title":"Hyperinsulinemia does not increase the risk of fatal cardiovascular disease in elderly men or women without diabetes: the Rancho Bernardo Study, 1984\u20131991","volume":"140","author":"Ferrara","year":"1994","journal-title":"Am J Epidemiol."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB55","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1161\/01.ATV.11.4.1068","article-title":"Asymptomatic atherosclerosis and insulin resistance","volume":"11","author":"Laakso","year":"1991","journal-title":"Arteriosclerosis and Thrombosis."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB56","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s001250050581","article-title":"Insulin resistance and coronary artery disease","volume":"39","author":"Bressler","year":"1996","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB57","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1161\/01.CIR.93.10.1809","article-title":"Insulin sensitivity and atherosclerosis","volume":"93","author":"Howard","year":"1996","journal-title":"Circulation."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB58","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/diab.45.6.736","article-title":"Are insulin and proinsulin independent risk markers for premature coronary artery disease?","volume":"45","author":"Katz","year":"1996","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB59","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2337\/diab.45.6.742","article-title":"Increased insulin resistance and insulin secretion in non-diabetic African Americans and Hispanics compared with non-Hispanic whites: the Insulin Resistance Atherosclerosis Study","volume":"45","author":"Haffner","year":"1996","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB60","doi-asserted-by":"crossref","unstructured":"Fontbonne A, Eschw\u00e8ge E, Cambien F, et al. Hypertriglyceridemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes: results from the 11 year follow-up of the Paris Prospective Study. Diabetologia. 32:300\u2013304.","DOI":"10.1007\/BF00265546"},{"key":"10.1016\/S0002-9343(97)00027-2_BIB61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.2337\/diacare.15.7.820","article-title":"Coronary heart disease incidence in NIDDM patients in the Helsinki Heart Study","volume":"15","author":"Koskinen","year":"1992","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB62","doi-asserted-by":"crossref","first-page":"614","DOI":"10.2337\/diacare.20.4.614","article-title":"Cholesterol lowering with simvastatin improves prognosis of diabetic patients with coronary heart disease. A subgroup analyses of the Scandinavian Simvastatin Survival Study (4S)","volume":"20","author":"Py\u00f6r\u00e4l\u00e4","year":"1997","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB63","doi-asserted-by":"crossref","first-page":"3015","DOI":"10.1001\/jama.1993.03500230097036","article-title":"Expert Panel on detection, evaluation and treatment of high blood cholesterol in adults","volume":"269","year":"1993","journal-title":"JAMA."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB64","unstructured":"Miettinen H, Lehto S, Salomaa VV, M\u00e4h\u00f6nen M, Miemal\u00e4 M, Haffner SM, Py\u00f6r\u00e4l\u00e4 K, Tuomilehto J. Higher mortality after mayocardial infarction in diabetic than in non-diabetic patients. Diabetes Care. (in press)."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB65","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1001\/jama.1990.03450060069031","article-title":"Nicotinic acid as therapy for dyslipidemia in non-insulin dependent diabetes mellitus","volume":"264","author":"Garg","year":"1990","journal-title":"JAMA."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB66","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM198801143180204","article-title":"Lovastatin for lowering cholesterol levels in non-insulin dependent diabetes mellitus","volume":"318","author":"Garg","year":"1988","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB67","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1161\/01.ATV.15.5.678","article-title":"Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by Atorvastatin, a new HMG-CoA reductase inhibitor","volume":"15","author":"Nawrocki","year":"1995","journal-title":"Arterioscler Thromb Vasc Biol."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB68","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1001\/jama.1996.03530260042029","article-title":"Efficacy and safety of a new HMG-CoA reductase inhibitor, Atorvastatin, in patients with hypertriglyceridemia","volume":"275","author":"Bakker-Arkema","year":"1996","journal-title":"JAMA."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB69","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/diacare.5.3.322","article-title":"Improvement of the plasma lipoprotein pattern after institution of insulin treatment in diabetes mellitus","volume":"5","author":"Agardh","year":"1982","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB70","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.2337\/diab.35.11.1268","article-title":"Effects of NIDDM on very low density lipoprotein triglyceride and apolipoprotein B metabolism: studies before and after sulfonylurea therapy","volume":"35","author":"Taskinen","year":"1986","journal-title":"Diabetes."},{"issue":"Suppl","key":"10.1016\/S0002-9343(97)00027-2_BIB71","first-page":"46","article-title":"High serum insulin concentrations in relation to other cardiovascular risk factors in macrovascular disease of type 2 diabetes","volume":"15","author":"Standl","year":"1985","journal-title":"Horm Metab Res."},{"issue":"Suppl 2","key":"10.1016\/S0002-9343(97)00027-2_BIB72","first-page":"789","article-title":"A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results","volume":"19","author":"Meinert","year":"1970","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB73","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diacare.18.8.1113","article-title":"for the VA CSDM group. Veterans affairs cooperative study on glycemic control and complications in type II diabetes (VA CSDM). Results of the feasibility trial","volume":"18","author":"Abraira","year":"1995","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB74","doi-asserted-by":"crossref","first-page":"131","DOI":"10.7326\/0003-4819-124-1_Part_2-199601011-00010","article-title":"The feasibility of intensive insulin management in non-insulin-dependent diabetes mellitus. Implications of the Veterans Affairs Cooperative Study on glycemic control and complications in NIDDM","volume":"124","author":"Colwell","year":"1996","journal-title":"Ann Intern Med."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB75","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1001\/archinte.1997.00440230053007","volume":"157","author":"Abraira","year":"1997","journal-title":"Arch Intern Med."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB76","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB77","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB78","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2337\/diacare.13.6.631","article-title":"Insulin and atheroma: 20-year perspective","volume":"13","author":"Stout","year":"1990","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB79","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/diacare.16.11.1517","article-title":"Implications of the diabetes control and complications trial","volume":"16","year":"1993","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB80","first-page":"404","article-title":"I. Effect of diet, sulphonylurea, insulin or biguanide therapy on fasting plasma glucose and body weight over one year","volume":"24","year":"1983","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB81","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/BF00400952","article-title":"Why is insulin not a risk factor for coronary heart disease?","volume":"37","author":"Jarrett","year":"1994","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB82","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/BF00400953","article-title":"Insulin resistance, compensatory hyperinsulinemia, and coronary heart disease","volume":"37","author":"Reaven","year":"1994","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB83","doi-asserted-by":"crossref","unstructured":"Fontbonne A. Why can high insulin levels indicate a risk for coronary heart disease? Diabetologia. 37:953\u2013955","DOI":"10.1007\/s001250050203"},{"key":"10.1016\/S0002-9343(97)00027-2_BIB84","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1007\/BF00400955","article-title":"The insulin resistance syndrome: the controversy is dead, long live the controversy!","volume":"37","author":"Stern","year":"1994","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB85","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/diab.46.1.63","article-title":"Insulin sensitivity and acute insulin response in African-American, non-Hispanic whites, and Hispanics with NIDDM. The Insulin Resistance Atherosclerosis Study","volume":"46","author":"Haffner","year":"1997","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB86","doi-asserted-by":"crossref","first-page":"784","DOI":"10.2337\/diab.38.6.784","article-title":"Insulin-sensitive and insulin-resistant variants in NIDDM","volume":"38","author":"Banerji","year":"1989","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB87","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.2337\/diacare.14.11.1036","article-title":"Patterns of glucose and lipid abnormalities in black NIDDM subjects","volume":"14","author":"Chaiken","year":"1991","journal-title":"Diabetes Care."},{"issue":"Suppl 1","key":"10.1016\/S0002-9343(97)00027-2_BIB88","first-page":"A278","article-title":"Insulin resistance is associated with more atherogenic cardiovascular risk factors in diabetes. Presented at the 1996 EASD meeting. September, 1996. Vienna, Austria","volume":"39","author":"D\u2019Agostino","year":"1996","journal-title":"Diabetologia."},{"issue":"Suppl 3","key":"10.1016\/S0002-9343(97)00027-2_BIB89","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00003495-199200443-00004","article-title":"Oral antidiabetic agents: the emergence of alpha-glucosidase inhibitors","volume":"44","author":"Lebovitz","year":"1992","journal-title":"Drugs."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB90","doi-asserted-by":"crossref","first-page":"737","DOI":"10.2337\/diacare.15.6.737","article-title":"Sulfonylureas in NIDDM","volume":"15","author":"Groop","year":"1992","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB91","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2337\/diacare.18.11.1510","article-title":"The pharmacological treatment of hyperglycemia in NIDDM","volume":"18","year":"1995","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB92","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1056\/NEJM199211123272005","article-title":"Comparison of insulin regimens in patients with non-insulin-dependent diabetes mellitus","volume":"327","author":"Yki-Jarvinen","year":"1992","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB93","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1056\/NEJM199508313330902","article-title":"for the Multicenter Metformin Study Group. Efficacy of Metformin in patients with non-insulin dependent diabetes mellitus","volume":"333","author":"DeFronzo","year":"1995","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB94","doi-asserted-by":"crossref","first-page":"928","DOI":"10.7326\/0003-4819-121-12-199412150-00004","article-title":"The efficacy of acarbose in treatment of patients with non-insulin-dependent diabetes mellitus: a multicenter controlled clinical trial","volume":"121","author":"Chiasson","year":"1994","journal-title":"Ann Intern Med."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB95","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/diacare.15.2.193","article-title":"Metabolic effects of new oral hypoglycemic agent CS-045 in NIDDM subjects","volume":"15","author":"Suter","year":"1992","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB96","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1056\/NEJM199411033311803","article-title":"Improvement in glucose tolerance and insulin resistance in obese subjects treated with Troglitazone","volume":"331","author":"Nolan","year":"1994","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB97","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2337\/diacare.19.2.151","article-title":"Effects of Troglitazone. A new hypoglycemic agent in patients with NIDDM poorly controlled by diet therapy","volume":"19","author":"Iwamoto","year":"1996","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB98","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJM199411033311812","article-title":"Insulin resistance and the prevention of diabetes mellitus","volume":"331","author":"Keen","year":"1994","journal-title":"NEJM."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF00275938","article-title":"Diabetes and arterial hypertension","volume":"24","author":"Drury","year":"1983","journal-title":"Diabetologia."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB100","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1136\/bmj.289.6457.1495","article-title":"Do antihypertensive drugs precipitate diabetes?","volume":"289","author":"Bengtsson","year":"1984","journal-title":"BMJ."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB101","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1464-5491.1988.tb00981.x","article-title":"Diabetes in hypertensive women: an effect of antihypertensive drugs or the hypertensive state per se?","volume":"5","author":"Bengtsson","year":"1988","journal-title":"Diabet Med."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB102","doi-asserted-by":"crossref","unstructured":"Skarfors ET, Lithell HO, Selinus I, Aberg H. Do antihypertensive drugs precipitate diabetes in predisposed men? BMJ. 298:1147\u20131152","DOI":"10.1136\/bmj.298.6681.1147"},{"key":"10.1016\/S0002-9343(97)00027-2_BIB103","doi-asserted-by":"crossref","first-page":"154","DOI":"10.2337\/diab.42.1.154","article-title":"Incidence of NIDDM and impaired glucose tolerance in hypertensive subjects: the San Antonio Heart Study","volume":"42","author":"Morales","year":"1993","journal-title":"Diabetes."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB104","first-page":"1425","article-title":"Increased risk of non-insulin dependent diabetes mellitus in elderly hypertensive subjects","volume":"12","author":"Mykk\u00e4nen","year":"1994","journal-title":"J Hypertension."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB105","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/diacare.14.3.203","article-title":"Effect of antihypertensive drugs on insulin, glucose, and lipid metabolism","volume":"14","author":"Lithell","year":"1991","journal-title":"Diabetes Care."},{"key":"10.1016\/S0002-9343(97)00027-2_BIB106","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-118-4-199302150-00005","article-title":"Antihypertensive drug therapy and the initiation of treatment for diabetes mellitus","volume":"118","author":"Gurwitz","year":"1993","journal-title":"Ann Intern Med."}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934397000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934397000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T07:59:42Z","timestamp":1757577582000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934397000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,8]]},"references-count":106,"journal-issue":{"issue":"2","published-print":{"date-parts":[[1997,8]]}},"alternative-id":["S0002934397000272"],"URL":"https:\/\/doi.org\/10.1016\/s0002-9343(97)00027-2","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[1997,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin Resistance Implications for Type II Diabetes Mellitus and Coronary Heart Disease","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S0002-9343(97)00027-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"converted-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 1997 Elsevier Science Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}